Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Did Moderna's COVID Vaccine Results in Teens Stack Up Against Pfizer's?


Pfizer's (NYSE: PFE) COVID-19 vaccine is already available to teens. Moderna's (NASDAQ: MRNA) might not be too far behind. The company recently announced positive results from a clinical study of its vaccine in children between the ages of 12 and 18. In this Motley Fool Live video recorded on May 26, Motley Fool contributors Keith Speights and Brian Orelli discuss how Moderna's results stack up against Pfizer's.

Continue reading


Source Fool.com

Like: 0
Share

Comments